These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 36301490)

  • 1. Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.
    Adhikari S; Guha D; Mohan C; Mukherjee S; Tyler JK; Das C
    Subcell Biochem; 2022; 100():3-65. PubMed ID: 36301490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and metabolism in cancer.
    Bensaad K; Harris AL
    Adv Exp Med Biol; 2014; 772():1-39. PubMed ID: 24272352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential molecular mechanistic behavior of HDACs in cancer progression.
    Singh T; Kaur P; Singh P; Singh S; Munshi A
    Med Oncol; 2022 Aug; 39(11):171. PubMed ID: 35972597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.
    Zhou J; Ma X; Liu X; Liu Y; Fu J; Qi Y; Liu H
    Genes Genomics; 2024 Sep; 46(9):991-1011. PubMed ID: 39127851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development.
    Zheng X; Fan H; Liu Y; Wei Z; Li X; Wang A; Chen W; Lu Y
    Curr Mol Pharmacol; 2022; 15(3):487-501. PubMed ID: 34382521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.
    Xu X; Peng Q; Jiang X; Tan S; Yang Y; Yang W; Han Y; Chen Y; Oyang L; Lin J; Xia L; Peng M; Wu N; Tang Y; Li J; Liao Q; Zhou Y
    Exp Mol Med; 2023 Jul; 55(7):1357-1370. PubMed ID: 37394582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significant role of amino acid metabolic reprogramming in cancer.
    Liu X; Ren B; Ren J; Gu M; You L; Zhao Y
    Cell Commun Signal; 2024 Jul; 22(1):380. PubMed ID: 39069612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
    Fukushi A; Kim HD; Chang YC; Kim CH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells.
    Wang K; Lu Y; Li H; Zhang J; Ju Y; Ouyang M
    Cancer Cell Int; 2024 Jan; 24(1):15. PubMed ID: 38184562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
    Hao X; Ren Y; Feng M; Wang Q; Wang Y
    Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and cancer metabolism.
    Johnson C; Warmoes MO; Shen X; Locasale JW
    Cancer Lett; 2015 Jan; 356(2 Pt A):309-14. PubMed ID: 24125862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connections between metabolism and epigenetics in cancers.
    Thakur C; Chen F
    Semin Cancer Biol; 2019 Aug; 57():52-58. PubMed ID: 31185282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
    Pang Y; Lu T; Xu-Monette ZY; Young KH
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer.
    Camuzi D; de Amorim ÍSS; Ribeiro Pinto LF; Oliveira Trivilin L; Mencalha AL; Soares Lima SC
    Cells; 2019 Apr; 8(4):. PubMed ID: 30939818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.